Literature DB >> 30474097

Recent advances in gold-NHC complexes with biological properties.

Malka Mora1, M Concepción Gimeno2, Renso Visbal3.   

Abstract

This tutorial review covers the recent advances made in the study of gold complexes containing N-heterocyclic carbene ligands with biological properties. The great stability, ease of modulation of the electronic properties and excellent σ-donating capacity displayed by NHCs allow gold-NHC derivatives to reach high stability in biological media and relatively good internalization into cells and for that they have emerged as excellent potential chemotherapeutics. The new gold-NHC derivatives show superior anticancer activity compared to other standards such as Cisplatin or Auranofin. In addition, the application of gold-NHC complexes in the treatment of other human diseases as antibacterial, antioxidant and antiparasitic agents is reviewed for the first time.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30474097     DOI: 10.1039/c8cs00570b

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  38 in total

1.  Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugation.

Authors:  Sajal Sen; Yue Li; Vincent Lynch; Kuppuswamy Arumugam; Jonathan L Sessler; Jonathan F Arambula
Journal:  Chem Commun (Camb)       Date:  2019-08-29       Impact factor: 6.222

2.  Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.

Authors:  Natalia Curado; Nora Giménez; Kirill Miachin; Mélanie Aliaga-Lavrijsen; Mike A Cornejo; Andrzej A Jarzecki; María Contel
Journal:  ChemMedChem       Date:  2019-04-12       Impact factor: 3.466

3.  Synthesis of N-heterocyclic carbene gold(I) complexes.

Authors:  Fady Nahra; Nikolaos V Tzouras; Alba Collado; Steven P Nolan
Journal:  Nat Protoc       Date:  2021-01-27       Impact factor: 13.491

4.  Crystal structures of the gold NHC complex bis-(4-bromo-1,3-di-ethyl-imidazol-2-yl-idene)gold(I) iodide and its 1:1 adduct with trans-bis-(4-bromo-1,3-diethyl-imidazol-2-yl-idene)di-iodido-gold(III) iodide.

Authors:  Rolf Büssing; Ingo Ott; Peter G Jones
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-11-09

5.  Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 inhibitors.

Authors:  Brandon Putterill; Charles Rono; Banothile Makhubela; Debra Meyer; Ntombenhle Gama
Journal:  Biometals       Date:  2022-06-14       Impact factor: 3.378

6.  Dinuclear Au(I), Au(II) and Au(III) Complexes with (CF2 )n Chains: Insights into The Role of Aurophilic Interactions in the Au(I) Oxidation.

Authors:  Alejandro Portugués; Delia Bautista; Juan Gil-Rubio
Journal:  Chemistry       Date:  2021-09-29       Impact factor: 5.020

7.  Rollover Cyclometalation vs Nitrogen Coordination in Tetrapyridyl Anticancer Gold(III) Complexes: Effect on Protein Interaction and Toxicity.

Authors:  Xue-Quan Zhou; Imma Carbo-Bague; Maxime A Siegler; Jonathan Hilgendorf; Uttara Basu; Ingo Ott; Rongfang Liu; Liyan Zhang; Vadde Ramu; Adriaan P IJzerman; Sylvestre Bonnet
Journal:  JACS Au       Date:  2021-03-16

8.  Reaction of chloroauric acid with histidine in microdroplets yields a catalytic Au-(His)2 complex.

Authors:  Kai Luo; Jia Li; Yufei Cao; Chengyuan Liu; Jun Ge; Hao Chen; Richard N Zare
Journal:  Chem Sci       Date:  2020-01-31       Impact factor: 9.825

9.  Antibacterial Thiamine inspired silver (I) and gold (I) N-heterocyclic carbene compounds.

Authors:  Orhi Esarte Palomero; Ashley L Cunningham; Bryan W Davies; Richard A Jones
Journal:  Inorganica Chim Acta       Date:  2020-11-27       Impact factor: 2.545

10.  Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic Studies.

Authors:  Leila Tabrizi; Won Seok Yang; Chetan Chintha; Liam Morrison; Afshin Samali; Joe W Ramos; Andrea Erxleben
Journal:  Eur J Inorg Chem       Date:  2021-05-11       Impact factor: 2.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.